Analytics

Aug 14, 2017
By Pharmaceutical Technology Editors
The expansion at its Lincolnshire, IL, facility will double the footprint of the site’s range of services, including microbiological evaluation, drug stability studies, and medical devices testing.
Aug 10, 2017
Artificial intelligence offers a number of opportunities in pharmaceutical drug development and manufacturing, but there are barriers to overcome, notably around how well and how quickly the regulatory environment can adapt and keep pace with to the rapid changes.
Aug 02, 2017
Pharmaceutical Technology
Statistical methods and novel indices can be used to monitor and benchmark variability, and guide continuous improvement programs in late-stage drug development.
Aug 02, 2017
Pharmaceutical Technology
The author describes how to establish acceptance limits for acceptance value (AV) data for process validation batches, typical characteristics of AV distributions, and how to derive relevant constants for AV control charts in annual product review and continued process verification reports.
Aug 02, 2017
Pharmaceutical Technology
Managing and prioritizing risk is essential to ensuring raw material quality. USP is developing new guidelines to make the work easier.
Aug 02, 2017
Pharmaceutical Technology
Amid contentious debate about “fake news,” peer-review papers offer vital, objective insight.
Jul 18, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Catalent expands the scope of the OptiForm Solution Suite to bridge gap from late-stage discovery to Phase I trials.
Jul 05, 2017
By Pharmaceutical Technology Editors
A Supreme Court decision and improvements in analytical processes may speed the biosimilar approval process.
Jul 02, 2017
Pharmaceutical Technology
The author reviews key technological expectations of EU GMP inspectors on the integrity of e-records.
Jul 02, 2017
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Cheaper drugs are good for consumers, but cost restrictions limit drug company incentives to modernize facilities.
native1_300x100
lorem ipsum